Conference icon

Conference

Improvement in Signs and Symptoms of Active Ankylosing Spondylitis Following Treatment with Anti-Interleukin (IL)-17A Monoclonal Antibody Secukinumab Are Paralleled by Reductions in Acute Phase Markers and Inflammatory Markers S100A8 and A9 (Calgranulin A and B)

Publication status:
Published

Actions


Authors


Baeten, DL More by this author
Brachat, A More by this author
Expand authors...
Volume:
64
Issue:
10
Pages:
S942-S942
Publication date:
2012-10-05
ISSN:
0004-3591
URN:
uuid:e35bda09-8796-4a32-bd25-442236e1c127
Source identifiers:
366435
Local pid:
pubs:366435

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP